Nova Mentis Life Science Corp
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company has collaboration with the University … Read more
Market Cap & Net Worth: Nova Mentis Life Science Corp (NMLSF)
Nova Mentis Life Science Corp (PINK:NMLSF) has a market capitalization of $1.54 Million ($1.54 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #35342 globally and #11519 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nova Mentis Life Science Corp's stock price $0.04 by its total outstanding shares 36550355 (36.55 Million).
Nova Mentis Life Science Corp Market Cap History: 2015 to 2025
Nova Mentis Life Science Corp's market capitalization history from 2015 to 2025. Data shows change from $17.84 Million to $1.54 Million (-22.81% CAGR).
Nova Mentis Life Science Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nova Mentis Life Science Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
93.52x
Nova Mentis Life Science Corp's market cap is 93.52 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $30.13 Million | $7.19K | -$1.40 Million | 4189.67x | N/A |
| 2020 | $30.73 Million | $11.47K | -$25.23 Million | 2678.51x | N/A |
| 2021 | $7.79 Million | $1.53K | -$2.68 Million | 5101.72x | N/A |
| 2023 | $2.38 Million | $25.41K | -$1.22 Million | 93.52x | N/A |
Competitor Companies of NMLSF by Market Capitalization
Companies near Nova Mentis Life Science Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Nova Mentis Life Science Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Nova Mentis Life Science Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Nova Mentis Life Science Corp's market cap moved from $17.84 Million to $ 1.54 Million, with a yearly change of -22.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.54 Million | +61.92% |
| 2024 | $950.31K | -60.00% |
| 2023 | $2.38 Million | -81.43% |
| 2022 | $12.79 Million | +64.32% |
| 2021 | $7.79 Million | -74.66% |
| 2020 | $30.73 Million | +1.98% |
| 2019 | $30.13 Million | -41.11% |
| 2018 | $51.17 Million | -89.04% |
| 2017 | $466.89 Million | +552.40% |
| 2016 | $71.57 Million | +301.23% |
| 2015 | $17.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nova Mentis Life Science Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.54 Million USD |
| MoneyControl | $1.54 Million USD |
| MarketWatch | $1.54 Million USD |
| marketcap.company | $1.54 Million USD |
| Reuters | $1.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.